@article{10920,
  keywords = {Adult, Age Factors, Aged, Diabetes Mellitus, Type 2/drug therapy, Diabetic Ketoacidosis/*chemically induced, Dipeptidyl-Peptidase IV Inhibitors/adverse effects/therapeutic use, Female, Humans, Hypoglycemic Agents/*adverse effects/therapeutic use, Male, Middle Aged, propensity score, Proportional Hazards Models, Retrospective Studies, Risk Factors, Sex Factors, Sodium-Glucose Transporter 2 Inhibitors/*adverse effects/therapeutic use, Young Adult},
  author = {A. Douros and L. Lix and M. Fralick and S. Dell'Aniello and B. Shah and P. Ronksley and É Tremblay and N. Hu and S. Alessi-Severini and A. Fisher and S. Bugden and P. Ernst and K. Filion},
  title = {Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study},
  year = {2020},
  journal = {Ann Intern Med},
  volume = {173},
  edition = {2020/07/28},
  number = {6},
  pages = {417-425},
  isbn = {0003-4819},
  doi = {10.7326/m20-0289},
  note = {1539-3704
Douros, Antonios
Orcid: 0000-0002-6005-4006
Lix, Lisa M
Fralick, Michael
Dell'Aniello, Sophie
Shah, Baiju R
Orcid: 0000-0003-3598-3628
Ronksley, Paul E
Tremblay, Éric
Hu, Nianping
Alessi-Severini, Silvia
Fisher, Anat
Orcid: 0000-0001-9730-5107
Bugden, Shawn C
Ernst, Pierre
Orcid: 0000-0001-9983-3608
Filion, Kristian B
Canadian Network for Observational Drug Effect Studies (CNODES) Investigators
DSE-146021/CIHR/Canada
Comparative Study
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
United States
Ann Intern Med. 2020 Sep 15;173(6):417-425. doi: 10.7326/M20-0289. Epub 2020 Jul 28.},
  language = {eng},
}